Influence of cysteamine and cysteine on open-field behaviour, and on brain concentrations of catecholamines, somatostatin, neuropeptide Y, and corticotropin releasing hormone in the rat

L. Vécsei, R. Ekman, C. Alling, E. Widerlöv

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Cysteamine (1.95 or 3.90 mM/kg) administered subcutaneously (sc) markedly decreased the open-field activity of the rats, while the structurally related amino acid cysteine had only minor influence. Cysteamine (1.95 or 3.90 mM/kg) reduced the noradrenaline and increased the dopamine and dihydroxyphenyl acetic acid (DOPAC) levels in the hypothalamus. In striatum the drug decreased both the noradrenaline (1.95 or 3.90 mM/kg) and dopamine (3.90 mM/kg) levels without influencing the DOPAC content. Neither the hypothalamic nor the striatal catecholamines are influenced by administration of equimolar doses of cysteine. Cysteamine (1.95 or 3.90 mM/kg) decreased the somatostatin levels both in the hypothalamus and in the striatum without influencing neuropeptide Y (NPY) and corticotropin releasing hormone (CRH) concentrations. Cysteine administered in equimolar doses did not influence the peptide levels in these brain structures. These data suggest that the cysteamine-induced behavioural changes are related to the decrease of brain noradrenaline and somatostatin concentrations. The structurally related amino acid cystein does not influence the behaviour or the central monoaminergic and peptidergic concentrations in the hypothalamus and striatum of rats.

Original languageEnglish
Pages (from-to)209-220
Number of pages12
JournalJournal of Neural Transmission
Volume78
Issue number3
DOIs
Publication statusPublished - Oct 1989

Fingerprint

Cysteamine
Neuropeptide Y
Corticotropin-Releasing Hormone
Somatostatin
Catecholamines
Cysteine
Hypothalamus
Norepinephrine
Brain
Acetic Acid
Dopamine
Corpus Striatum
Amino Acids
Peptides
Pharmaceutical Preparations

Keywords

  • Catecholamines
  • corticotropin releasing hormone (CRH)
  • cysteamine
  • cysteine
  • neuropeptide Y (NPY)
  • open field behaviour
  • rats
  • somatostatin

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

@article{8dd6c10e576c4ec484ab2d5dca4495c5,
title = "Influence of cysteamine and cysteine on open-field behaviour, and on brain concentrations of catecholamines, somatostatin, neuropeptide Y, and corticotropin releasing hormone in the rat",
abstract = "Cysteamine (1.95 or 3.90 mM/kg) administered subcutaneously (sc) markedly decreased the open-field activity of the rats, while the structurally related amino acid cysteine had only minor influence. Cysteamine (1.95 or 3.90 mM/kg) reduced the noradrenaline and increased the dopamine and dihydroxyphenyl acetic acid (DOPAC) levels in the hypothalamus. In striatum the drug decreased both the noradrenaline (1.95 or 3.90 mM/kg) and dopamine (3.90 mM/kg) levels without influencing the DOPAC content. Neither the hypothalamic nor the striatal catecholamines are influenced by administration of equimolar doses of cysteine. Cysteamine (1.95 or 3.90 mM/kg) decreased the somatostatin levels both in the hypothalamus and in the striatum without influencing neuropeptide Y (NPY) and corticotropin releasing hormone (CRH) concentrations. Cysteine administered in equimolar doses did not influence the peptide levels in these brain structures. These data suggest that the cysteamine-induced behavioural changes are related to the decrease of brain noradrenaline and somatostatin concentrations. The structurally related amino acid cystein does not influence the behaviour or the central monoaminergic and peptidergic concentrations in the hypothalamus and striatum of rats.",
keywords = "Catecholamines, corticotropin releasing hormone (CRH), cysteamine, cysteine, neuropeptide Y (NPY), open field behaviour, rats, somatostatin",
author = "L. V{\'e}csei and R. Ekman and C. Alling and E. Widerl{\"o}v",
year = "1989",
month = "10",
doi = "10.1007/BF01249230",
language = "English",
volume = "78",
pages = "209--220",
journal = "Journal of Neural Transmission",
issn = "0300-9564",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Influence of cysteamine and cysteine on open-field behaviour, and on brain concentrations of catecholamines, somatostatin, neuropeptide Y, and corticotropin releasing hormone in the rat

AU - Vécsei, L.

AU - Ekman, R.

AU - Alling, C.

AU - Widerlöv, E.

PY - 1989/10

Y1 - 1989/10

N2 - Cysteamine (1.95 or 3.90 mM/kg) administered subcutaneously (sc) markedly decreased the open-field activity of the rats, while the structurally related amino acid cysteine had only minor influence. Cysteamine (1.95 or 3.90 mM/kg) reduced the noradrenaline and increased the dopamine and dihydroxyphenyl acetic acid (DOPAC) levels in the hypothalamus. In striatum the drug decreased both the noradrenaline (1.95 or 3.90 mM/kg) and dopamine (3.90 mM/kg) levels without influencing the DOPAC content. Neither the hypothalamic nor the striatal catecholamines are influenced by administration of equimolar doses of cysteine. Cysteamine (1.95 or 3.90 mM/kg) decreased the somatostatin levels both in the hypothalamus and in the striatum without influencing neuropeptide Y (NPY) and corticotropin releasing hormone (CRH) concentrations. Cysteine administered in equimolar doses did not influence the peptide levels in these brain structures. These data suggest that the cysteamine-induced behavioural changes are related to the decrease of brain noradrenaline and somatostatin concentrations. The structurally related amino acid cystein does not influence the behaviour or the central monoaminergic and peptidergic concentrations in the hypothalamus and striatum of rats.

AB - Cysteamine (1.95 or 3.90 mM/kg) administered subcutaneously (sc) markedly decreased the open-field activity of the rats, while the structurally related amino acid cysteine had only minor influence. Cysteamine (1.95 or 3.90 mM/kg) reduced the noradrenaline and increased the dopamine and dihydroxyphenyl acetic acid (DOPAC) levels in the hypothalamus. In striatum the drug decreased both the noradrenaline (1.95 or 3.90 mM/kg) and dopamine (3.90 mM/kg) levels without influencing the DOPAC content. Neither the hypothalamic nor the striatal catecholamines are influenced by administration of equimolar doses of cysteine. Cysteamine (1.95 or 3.90 mM/kg) decreased the somatostatin levels both in the hypothalamus and in the striatum without influencing neuropeptide Y (NPY) and corticotropin releasing hormone (CRH) concentrations. Cysteine administered in equimolar doses did not influence the peptide levels in these brain structures. These data suggest that the cysteamine-induced behavioural changes are related to the decrease of brain noradrenaline and somatostatin concentrations. The structurally related amino acid cystein does not influence the behaviour or the central monoaminergic and peptidergic concentrations in the hypothalamus and striatum of rats.

KW - Catecholamines

KW - corticotropin releasing hormone (CRH)

KW - cysteamine

KW - cysteine

KW - neuropeptide Y (NPY)

KW - open field behaviour

KW - rats

KW - somatostatin

UR - http://www.scopus.com/inward/record.url?scp=0024342547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024342547&partnerID=8YFLogxK

U2 - 10.1007/BF01249230

DO - 10.1007/BF01249230

M3 - Article

VL - 78

SP - 209

EP - 220

JO - Journal of Neural Transmission

JF - Journal of Neural Transmission

SN - 0300-9564

IS - 3

ER -